Guardant Health (GH) EPS (Weighted Average and Diluted): 2019-2025
Historic EPS (Weighted Average and Diluted) for Guardant Health (GH) over the last 6 years, with Sep 2025 value amounting to -$0.74.
- Guardant Health's EPS (Weighted Average and Diluted) rose 15.91% to -$0.74 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.21, marking a year-over-year increase of 25.00%. This contributed to the annual value of -$3.56 for FY2024, which is 16.82% up from last year.
- Guardant Health's EPS (Weighted Average and Diluted) amounted to -$0.74 in Q3 2025, which was up 7.50% from -$0.80 recorded in Q2 2025.
- Guardant Health's EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.67 during Q2 2023, with a 5-year trough of -$2.25 in Q2 2022.
- Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$0.84 (2024), whereas its average is -$0.93.
- Per our database at Business Quant, Guardant Health's EPS (Weighted Average and Diluted) tumbled by 220.00% in 2021 and then skyrocketed by 70.22% in 2023.
- Quarterly analysis of 5 years shows Guardant Health's EPS (Weighted Average and Diluted) stood at -$0.89 in 2021, then plummeted by 53.93% to -$1.37 in 2022, then declined by 18.25% to -$1.62 in 2023, then skyrocketed by 44.44% to -$0.90 in 2024, then rose by 15.91% to -$0.74 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.74 in Q3 2025, compared to -$0.80 in Q2 2025 and -$0.77 in Q1 2025.